1. 1)ANTI-HISTAMINES 2)ANTI-TUSSIVE MODIFIED BY Israa

2. Classification of antihistamines They are classified into H 1 -blockers & H 2 -blockers. No currently available antagonist for H 3 or H 4 Receptors H 1 -blockers: They block the histamine action on H1 receptors Best work if given before histamine release (prophylactically ) because they only bind to the free receptors Can be divided in to 1.First Generation: Sedating 2.Second Generation: Non-sedating

3. First Generation Agents Ethanol-amines: DIPHEN-HYDRAMINE Ethylene-di-amine: TRI-PELENNAMINE Alkyl-amine: CHLORPHENIRAMINE Phenothiazine: PROMETHAZINE (Phenergan) Piperazines: HYDROXYZINE

4. First Generation Agents uses In anaphylaxis (serious allergic reaction that is rapid in onset and may cause death.) and other cases where histamine release can occur (epinephrine must also be used) Anti-allergy (allergic rhinitis, allergic dermatoses, contact dermatitis) Sedative/sleep aid To prevent motion sickness Antiemetic: prophylactic for motion sickness Antivertigo Local anesthetic Antitussive

5. Pharmacokinetics for the first generation Are absorbed from the GIT. Can also be given parenterally & topically. Most of them are widely distributed throughout the body, but some do not penetrate the BBB, Are most effective when used prophylactically. Most of the them are metabolized extensively in the liver.

6. additional effects of the first generation Block H1 receptors in CNS→ sedation, dizziness & fatigue. Anticholinergic effect → dry mouth, urinary retention, tachycardia α- blocking effect →postural hypotension, reflex tachycardia. Antiserotonin effect → ↑appetite

8. Adverse Effects of the first generation Sedation (Paradoxical Excitation in children) Dizziness Fatigue Tachydysrhythmias in overdose - rare Peripheral antimuscarinic effects 1.dry Mouth 2.blurred Vision 3.constipation 4.urinary Retention

9. Adverse effects observed with first generation antihistamines

10. The use of first generation H 1 antihistamines is contraindicated in treatment of individuals working in jobs where wakefulness is critical

11. Second generation H 1 -blockers Examples for this group: loratadine,fexofinadine, cetirizine, astemazole Are specific for H 1 receptors. Do not penetrate the BBB so they show less CNS toxicity.

12. Pharmacokinetics for the second generation Cetirizine (C), loratadine (L), fexofenadine (F) are well absorbed and excreted mainly in unmetabolized form. C and L are primarily excreted in the urine F is primarily excreted in the feces They induce Cyt P450 liver enzymes

13. Adverse Effects of the second generation in general, these agents have a much lower incidence of adverse effects than the first generation agents. terfenadine and astemizole were removed from the market due to effects on cardiac K+ channels - prolong QT interval (potentially fatal arrhythmia “torsades de pointes”)> is an uncommon variant of ventricular tachycardia that can be the result of lengthening the QT interval.)

14. Treatment of cough Modified By :ISRAA

15. Treatment of Cough Antitussives (cough center suppressants) Expectorants Mucolytics Antihistamines Pharyngeal Demulcents (>is an agent that forms a soothing film over a mucous membrane, relieving minor pain and inflammation of the membrane.)mucous membrane

16. 1) Antitussive Antitussive drugs act by ill defined effect in the brain stem, depressing an even more poorly defined “cough center”. All opioid narcotic analgesic have antitussive properties in doses lower than those required for pain relief They have minimum analgesic and addictive properties Newer agent that only act peripherally on sensory nerves in bronchi are being assessed

17. i) CODIENE It is the gold standard treatment for cough suppression It decreases the sensitivity of cough center in the CNS to peripheral stimuli, decrease the mucosal secretion which thicken the sputum, and inhibit ciliary activity These therapeutic effect occur at doses lower than those required for analgesia but still observed some common side effect like constipation, dysphoria(An emotional state characterized by anxiety, depression, or unease.), and fatigue, in addition to addiction potential

18. ii) DEXTROMETHORPHAN Is a synthetic derivative of morphine that suppresses the response of the central cough center It has no analgesic effect, has low addictive profile, but may cause dysphoria at higher doses(An emotional state characterized by anxiety, depression, or unease.) Has significantly better side effect profile than codeine and has been demonstrated to be equally effective for cough suppression

19. 2) Expectorants (Mucokinetics) Act peripherally Increase bronchial secretion OR Decrease its viscosity and facilitates its removal by coughing Loose cough ► less tiring & more productive

20. Classification of Expectorants Classified into a) Directly acting E.g., Guaifenesin (glyceryl guaiacolate), Na+ & K+ citrate or acetate, b) Reflexly acting E.g., Ammonium salt

21. Directly acting expectorants i) Sodium & potassium citrate or Acetate They increase bronchial secretion by salt action ii) Guaifenesin Expectorant drug usually taken by mouth Available as single & also in combination MOA=Increase the volume & reduce the viscosity of secretion in trachea & bronchi Reflexly acting expectorants: Ammonium salts:Its expectorant action is caused by irritative action on the bronchial mucosa.It is also a Gastric irritants causing reflex increase in bronchial secretions + sweating

22. 3) Mucolytics Help in expectoration by liquefying the viscous tracheobronchial secretions E.g., Bromhexine, Acetyl cysteine, i) Bromhexine Synthetic derivative of vasicine(*Alkaloid & like Theophylline) MOA of Bromhexine a) Thinning & fragmentation of mucopolysaccaride fibers b) ↑ volume & ↓ viscosity of sputum

23. 3) Mucolytics ii) Acetylcysteine Given directly into respiratory tract MOA of acetylcysteine: Opens disulfide bond in mucoproteins of sputum =↓ viscosity Uses: Cystic fibrosis, Onset of action is quick---used 2-8 hourly Adverse effects: Nausea, vomiting, bronchospasm in bronchial asthma

24. 4) Antihistamines Added to antitussives/expectorant formulation Due to sedative anticholinergic actions produce relief from cough but lack selectivity for cough center No expectorant action = ▼ secretions (anticholinergic effect) Suitable for allergic cough E.g., Chlorpheniramine and diphenhydramine

25. 5) Pharyngeal demulcents(>is an agent that forms a soothing film over a mucous membrane, relieving minor pain and inflammation of the membrane.)mucous membrane Soothe the throat (directly & also by promoting salivation Reduces afferent impulses from inflamed/irritated pharyngeal mucosa Provide symptomatic relief in dry cough arising from throat E.g. lozenges, cough drops, glycerine, liquorice(*Sweet tea), honey

26. Good luck